Can you spot the flaw in this organizational chart?

Editorial: Stem cell board must fix flawed governance - Sacramento Opinion - Sacramento Editorial | Sacramento Bee: Klein set up a dueling, unworkable co-CEO structure between the board chair and the agency president, who should be in charge of the day-to-day activities of the institute in funding scientific research – with the board and chair in an oversight role. Instead, the board chair is involved in day-to-day operations and management. How can the board chair in such a role possibly do independent evaluation of the agency's activities?